Henoch-Schönlein purpura: recent advances.
Recent developments in relation to Henoch-Schönlein purpura (HSP) include: a) a proposed new classification of childhood vasculitides including new classification criteria for HSP; b) the identification of various, potentially important, genetic polymorphisms in HSP that may be relevant in terms of predisposition to or protection from complications; c) evidence that prophylactic steroid at the onset of disease does not protect against renal or gastrointestinal complications but does seem to have beneficial effects in treating them.
Dillon
M J
MJ
Nephro-Urology Unit, Institute of Child Health, University College London, London, UK. m.dillon@ich.ucl.ac.uk
D005767:Gastrointestinal Diseases / Q000209:etiology / Q000517:prevention & control; D020022:Genetic Predisposition to Disease; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D011695:IgA Vasculitis / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D009393:Nephritis / Q000209:etiology / Q000517:prevention & control; D011110:Polymorphism, Genetic / Q000235:genetics*; D009626:Terminology as Topic; D014657:Vasculitis / Q000276:immunology / Q000628:therapy*
D005938:Glucocorticoids